All Stories

  1. Quality by design-enabled development of a robust reversed phase high performance liquid chromatography method for simultaneous estimation of lutein and dexamethasone in nanoformulations
  2. Cannabidivarin: current evidence on pharmacological activity, biopharmaceutical limitations and clinical prospects
  3. Engineering Stimuli-Responsive Dendrimers for Drug Delivery: A 15-Year Review of Formulation Strategies and Routes of Administration
  4. QbD-Based Systematic Development of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) of Biochanin A with Enhanced Biopharmaceutical Attributes
  5. Formulating Pharma‐, Nutra‐, and Cosmeceutical Products from Herbal Substances
  6. A comprehensive update on cannabidiol, its formulations and drug delivery systems
  7. Solubility-permeability interplay of hydrotropic solubilization of piroxicam
  8. A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
  9. PEGylated G4 dendrimers as a promising nanocarrier for piperlongumine delivery: Synthesis, characterization, and anticancer activity
  10. Smart approaches for encouraging the blood donation
  11. A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines
  12. Computer Aided Pharmaceutics and Drug Delivery
  13. Authorship and Contributorship in Scientific Publications
  14. Lipids for Taste masking and Taste assessment in pharmaceutical formulations
  15. Fast Dissolving/Disintegrating Dosage Forms of Natural Active Compounds and Alternative Medicines
  16. Progresses and Challenges of Fast Dissolving/Disintegrating Dosage Forms in Manufacturing, Formulation Screening, Preclinical Testing and Drug Delivery
  17. Solubility-Permeability Interplay of Hydrotropic Solubilization Using Response Surface Methodology
  18. Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement
  19. Development and Evaluation of IER based Formulation of Ondansetron HCl
  20. The Solubility-Permeability Interplay for Solubility-Enabling Oral Formulations
  21. Transdermal applications of ethosomes – a detailed review
  22. Analysis of Solution and System Identification of Coupled Fractional Delay Differential Equation by Shifted Jacobi Polynomials
  23. Approved and Marketed Fast Dissolving/ Disintegrating Drug Products
  24. Clinical Studies on Fast Dissolving/Disintegrating Dosage Forms
  25. Excipients for Fast Dissolving /Disintegrating Tablets
  26. Fast Dissolving/Disintegrating Dosage Forms: Introducing through Development, Market, Pharmacopoeial and Regulatory Status
  27. Freeze Drying Technologies for Developing Fast Dissolving/Disintegrating Tablets
  28. Modifications in Conventional Tablet Compaction Technologies for Developing Fast Dissolving/ Disintegrating Tablets
  29. Novel Fast Dissolving/Disintegrating Dosage Forms
  30. Quality Assurance and Evaluation of Fast Dissolving/Disintegrating Dosage Forms
  31. Taste Masking in Fast Dissolving/Disintegrating Dosage Forms
  32. Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms
  33. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate
  34. Formulation and characterization of taste masked ondansetron–magnesium aluminum silicate adsorption systems
  35. taste assessment
  36. Formulation and evaluation of lipid based taste masked granules of ondansetron HCl
  37. Bitterness Score and its Correlation to Drug Concentration: An Approach for Estimating Bitterness Suppression in a Marketed Product of Ofloxacin
  38. Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using Box-Behnken statistical design
  39. A Proposed Methodology for In Vitro Evaluation of Bitterness in Drug Solutions and In Vitro Drug Release Samples
  40. Anti-histaminic Activity ofDesmostachya bipinnata
  41. Pharmacognostic standardization with various plant parts ofDesmostachya bipinnata
  42. Formulation, evaluation and 32full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres
  43. Phytosomes: Complexation, Utilisation and Commerical Status
  44. Strychnos nux-vomica seeds: Pharmacognostical standardization, extraction, and antidiabetic activity
  45. Dissolution rate enhancement of gliclazide by ordered mixing
  46. Effect of time on extraction of Ashwagandha in various Hydroalcoholic compositions and their anti-inflammatory activity
  47. Dissolution enhancement of drugs. part i: technologies and effect of carriers
  48. Mechanical Methods for Dry Particle Coating Processes and Their Applications in Drug Delivery and Development
  49. Dissolution Enhancement of Drugs. Part II: Effect of Carriers
  50. Design and Development of Gliclazide Mucoadhesive Microcapsules: In Vitro and In Vivo Evaluation
  51. The latest trends in the taste assessment of pharmaceuticals
  52. Ion-exchange resins: carrying drug delivery forward